SILDENAFIL CITRATE (SILDENAFIL CITRATE) — FDA Approval ANDA202506 (WATSON LABS INC)
SILDENAFIL CITRATE (SILDENAFIL CITRATE) — FDA Approval ANDA202506 (WATSON LABS INC) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: SILDENAFIL CITRATE; Active ingredients: SILDENAFIL CITRATE; Application number: ANDA202506.
| Brand name | SILDENAFIL CITRATE |
|---|---|
| Active ingredients | SILDENAFIL CITRATE |
| Application number | ANDA202506 |
| Sponsor | WATSON LABS INC |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | Discontinued |
| Products in application | 3 |
| First approval date | 20201125 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →